Alpha Cognition Inc. (ACOG) stock
ACOGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3064% above fair value
$8.60+0.68 (+8.59%)
Close on Nov 18, 2026Market cap $187.29MP/E –Yield –
Alpha Cognition operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Alpha Cognition's operating income for the twelve months ending Jun 30, 2026 was -$29.09M. For fiscal 2025 it was -$22.66M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$22.66M | – |
| FY2024 | Dec 31, 2024 | -$12.01M | – |
| FY2023 | Dec 31, 2023 | -$9.94M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.76M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.10M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.93M | – |
| Q3 FY2025 | Sep 30, 2025 | -$5.31M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.45M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.40M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.69M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.49M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.42M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.41M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.42M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.77M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.73M | – |
See a number that looks wrong?